Jean Brooks

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

Dave Singh, Jean Brooks, Gerry Hagan et al. · Thorax · 2008 · 177 citations · Full text

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

James F. Donohue, Dennis E. Niewoehner, Jean Brooks et al. · Respiratory Research · 2014 · 92 citations · Full text

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

James F. Donohue, Antonio Anzueto, Jean Brooks et al. · Respiratory Medicine · 2012 · 65 citations

Novel Lama Gsk573719, Advanced Lung Disease, Pulmonary Medicine +3

Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies

Thomas M. Siler, Edward Kerwin, Karen Singletary et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2015 · 64 citations · Full text